Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
Medtronic
Baxter
Harvard Business School
Boehringer Ingelheim

Last Updated: November 20, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 014740

See Plans and Pricing

« Back to Dashboard

NDA 014740 describes MENRIUM 5-4, which is a drug marketed by Roche and is included in one NDA. Additional details are available on the MENRIUM 5-4 profile page.

The generic ingredient in MENRIUM 5-4 is chlordiazepoxide; estrogens, esterified. There are nine drug master file entries for this compound. Additional details are available on the chlordiazepoxide; estrogens, esterified profile page.
Summary for 014740
Tradename:MENRIUM 5-4
Applicant:Roche
Ingredient:chlordiazepoxide; estrogens, esterified
Patents:0

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength5MG;0.2MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 004

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength5MG;0.4MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 006

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength10MG;0.4MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Expired US Patents for NDA 014740

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Roche MENRIUM 10-4 chlordiazepoxide; estrogens, esterified TABLET;ORAL 014740-006 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Roche MENRIUM 5-4 chlordiazepoxide; estrogens, esterified TABLET;ORAL 014740-004 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Roche MENRIUM 5-2 chlordiazepoxide; estrogens, esterified TABLET;ORAL 014740-002 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Medtronic
Harvard Business School
Mallinckrodt
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.